Teva

Top ten stories of the month

Top ten stories of the month

By Ben Hargreaves

This month’s round-up of the most popular stories of the month, featuring a bold prediction of future growth for Chinese biotech and bad news for a potential treatment for Alzheimer’s disease.

(Image: Getty/Phototechno)

Hired and Retired: Big pharma to biotech trend continues

By Ben Hargreaves

As the stream of executives flowing from large pharma companies to smaller biotechs builds into a torrent, another month has passed with a number of significant switches. Notably, two former Genentech employees, responsible for work on some of its bestselling...

(Image: Getty/Filipfoto)

US FDA eases Teva headache with Ajovy approval

By Flora Southey

Regulatory setbacks at Teva’s CMO facility in Korea have not halted the regulatory progression of preventive migraine treatment Ajovy, which has received US FDA approval.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers